Comparison of the incidence of T2DM
T2DM
In the next 4 years, there were 6 patients in the Probiotics group and 5 patients in the Placebo group who developed T2DM. Thus, the cumulative incidence of T2DM was 59.1% in the probiotic group and 54.5% in the placebo group within 6 years. As shown in Kaplan-Meier analysis of the cumulative incidence of T2DM within 6 years between the probiotics and placebo group.At the end of the 6-year follow-up, patients were grouped according to whether T2DM occurred. The age of the T2DM group was significantly older than the non-T2DM group (57.2 vs 53.7 years, 